236 related articles for article (PubMed ID: 26117821)
21. Comparison between two common methods for measuring Giardia lamblia susceptibility to antiparasitic drugs in vitro.
Cruz A; Isaura Sousa M; Azeredo Z; Carolina Silva M; Figueiredo de Sousa JC; Manso O; Cabral M
Acta Trop; 2003 Oct; 88(2):131-5. PubMed ID: 14516924
[TBL] [Abstract][Full Text] [Related]
22. Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.
Capparelli EV; Bricker-Ford R; Rogers MJ; McKerrow JH; Reed SL
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821451
[TBL] [Abstract][Full Text] [Related]
23. Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.
Freeman J; Baines SD; Todhunter SL; Huscroft GS; Wilcox MH
J Antimicrob Chemother; 2011 Jun; 66(6):1407-8. PubMed ID: 21393199
[No Abstract] [Full Text] [Related]
24. In vitro antiamoebic activity evaluation and docking studies of metronidazole-triazole hybrids.
Negi B; Raj KK; Siddiqui SM; Ramachandran D; Azam A; Rawat DS
ChemMedChem; 2014 Nov; 9(11):2439-44. PubMed ID: 25146853
[TBL] [Abstract][Full Text] [Related]
25. Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization.
Busatti HG; Alves RJ; Santana-Anjos KG; Gil FF; Cury MC; Vannier-Santos MA; Gomes MA
Diagn Microbiol Infect Dis; 2013 Feb; 75(2):160-4. PubMed ID: 23331963
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL
J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.
Peláez T; Alcalá L; Alonso R; Martín-López A; García-Arias V; Marín M; Bouza E
Antimicrob Agents Chemother; 2005 Mar; 49(3):1157-9. PubMed ID: 15728918
[TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
O'Connor R; Baines SD; Freeman J; Wilcox MH
J Antimicrob Chemother; 2008 Oct; 62(4):762-5. PubMed ID: 18606787
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial resistance in Clostridium difficile.
Huang H; Weintraub A; Fang H; Nord CE
Int J Antimicrob Agents; 2009 Dec; 34(6):516-22. PubMed ID: 19828299
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates.
Beena ; Kumar N; Rohilla RK; Roy N; Rawat DS
Bioorg Med Chem Lett; 2009 Mar; 19(5):1396-8. PubMed ID: 19195884
[TBL] [Abstract][Full Text] [Related]
31. Thiosemicarbazone fragment embedded within 1,2,4-triazole ring as inhibitors of Entamoeba histolytica.
Siddiqui SM; Salahuddin A; Azam A
Bioorg Med Chem Lett; 2012 Apr; 22(8):2768-71. PubMed ID: 22444681
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids.
Torres-Gómez H; Hernández-Núñez E; León-Rivera I; Guerrero-Alvarez J; Cedillo-Rivera R; Moo-Puc R; Argotte-Ramos R; Rodríguez-Gutiérrez Mdel C; Chan-Bacab MJ; Navarrete-Vázquez G
Bioorg Med Chem Lett; 2008 Jun; 18(11):3147-51. PubMed ID: 18486471
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
Mackin KE; Elliott B; Kotsanas D; Howden BP; Carter GP; Korman TM; Riley TV; Rood JI; Jenkin GA; Lyras D
Anaerobe; 2015 Aug; 34():80-3. PubMed ID: 25944720
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.
Goldstein EJ; Citron DM; Tyrrell KL; Warren YA
Anaerobe; 2010 Jun; 16(3):220-2. PubMed ID: 20044011
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiparasitic activity of 1H-benzimidazole derivatives.
Valdez J; Cedillo R; Hernández-Campos A; Yépez L; Hernández-Luis F; Navarrete-Vázquez G; Tapia A; Cortés R; Hernández M; Castillo R
Bioorg Med Chem Lett; 2002 Aug; 12(16):2221-4. PubMed ID: 12127542
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates.
Ibrahim MA; Panda SS; Birs AS; Serrano JC; Gonzalez CF; Alamry KA; Katritzky AR
Bioorg Med Chem Lett; 2014 Apr; 24(7):1856-61. PubMed ID: 24641976
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
[TBL] [Abstract][Full Text] [Related]
38. Double Sonogashira reactions on dihalogenated aminopyridines for the assembly of an array of 7-azaindoles bearing triazole and quinoxaline substituents at C-5: Inhibitory bioactivity against Giardia duodenalis trophozoites.
Leboho TC; Giri S; Popova I; Cock I; Michael JP; de Koning CB
Bioorg Med Chem; 2015 Aug; 23(15):4943-4951. PubMed ID: 26043947
[TBL] [Abstract][Full Text] [Related]
39. Metronidazole resistance in Clostridium difficile.
Johnson S; Sanchez JL; Gerding DN
Clin Infect Dis; 2000 Aug; 31(2):625-6. PubMed ID: 10987742
[No Abstract] [Full Text] [Related]
40. Subinhibitory concentrations of metronidazole increase biofilm formation in Clostridium difficile strains.
Vuotto C; Moura I; Barbanti F; Donelli G; Spigaglia P
Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
